INMB
Price
$1.96
Change
-$0.03 (-1.51%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
52.9M
35 days until earnings call
OGEN
Price
$1.31
Change
-$0.04 (-2.96%)
Updated
Sep 24, 12:07 PM (EDT)
Capitalization
5.57M
Interact to see
Advertisement

INMB vs OGEN

Header iconINMB vs OGEN Comparison
Open Charts INMB vs OGENBanner chart's image
INmune Bio
Price$1.96
Change-$0.03 (-1.51%)
Volume$8.57K
Capitalization52.9M
Oragenics
Price$1.31
Change-$0.04 (-2.96%)
Volume$270
Capitalization5.57M
INMB vs OGEN Comparison Chart in %
Loading...
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INMB vs. OGEN commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INMB is a Buy and OGEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (INMB: $1.99 vs. OGEN: $1.35)
Brand notoriety: INMB and OGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INMB: 32% vs. OGEN: 281%
Market capitalization -- INMB: $52.9M vs. OGEN: $5.57M
INMB [@Biotechnology] is valued at $52.9M. OGEN’s [@Biotechnology] market capitalization is $5.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INMB’s FA Score shows that 0 FA rating(s) are green whileOGEN’s FA Score has 0 green FA rating(s).

  • INMB’s FA Score: 0 green, 5 red.
  • OGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, OGEN is a better buy in the long-term than INMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INMB’s TA Score shows that 4 TA indicator(s) are bullish while OGEN’s TA Score has 5 bullish TA indicator(s).

  • INMB’s TA Score: 4 bullish, 3 bearish.
  • OGEN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both INMB and OGEN are a good buy in the short-term.

Price Growth

INMB (@Biotechnology) experienced а 0.00% price change this week, while OGEN (@Biotechnology) price change was +3.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.31%. For the same industry, the average monthly price growth was +10.10%, and the average quarterly price growth was +53.89%.

Reported Earning Dates

INMB is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+4.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INMB($52.9M) has a higher market cap than OGEN($5.57M). INMB YTD gains are higher at: -57.388 vs. OGEN (-87.815). OGEN has higher annual earnings (EBITDA): -9.51M vs. INMB (-39.72M). INMB has more cash in the bank: 33.4M vs. OGEN (1.97M). INMB has less debt than OGEN: INMB (451K) vs OGEN (3M). INMB has higher revenues than OGEN: INMB (50K) vs OGEN (0).
INMBOGENINMB / OGEN
Capitalization52.9M5.57M949%
EBITDA-39.72M-9.51M418%
Gain YTD-57.388-87.81565%
P/E RatioN/AN/A-
Revenue50K0-
Total Cash33.4M1.97M1,692%
Total Debt451K3M15%
FUNDAMENTALS RATINGS
INMB vs OGEN: Fundamental Ratings
INMB
OGEN
OUTLOOK RATING
1..100
322
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9665
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGEN's Valuation (54) in the Biotechnology industry is in the same range as INMB (77). This means that OGEN’s stock grew similarly to INMB’s over the last 12 months.

OGEN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as INMB (100). This means that OGEN’s stock grew similarly to INMB’s over the last 12 months.

INMB's SMR Rating (99) in the Biotechnology industry is in the same range as OGEN (100). This means that INMB’s stock grew similarly to OGEN’s over the last 12 months.

OGEN's Price Growth Rating (65) in the Biotechnology industry is in the same range as INMB (96). This means that OGEN’s stock grew similarly to INMB’s over the last 12 months.

OGEN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as INMB (100). This means that OGEN’s stock grew similarly to INMB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INMBOGEN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 16 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOC18.890.39
+2.11%
Healthpeak Properties
FPI10.89N/A
N/A
Farmland Partners
OSW21.64-0.55
-2.48%
OneSpaWorld Holdings Limited
ULY3.82-0.13
-3.29%
Urgently Inc.
COYA5.25-0.22
-4.02%
Coya Therapeutics

INMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMB has been loosely correlated with UNBX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if INMB jumps, then UNBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMB
1D Price
Change %
INMB100%
+0.51%
UNBX - INMB
51%
Loosely correlated
+5.59%
OGEN - INMB
44%
Loosely correlated
+0.75%
GBIO - INMB
36%
Loosely correlated
-0.86%
PROK - INMB
36%
Loosely correlated
-2.49%
OVID - INMB
35%
Loosely correlated
-2.33%
More

OGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with INMB. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then INMB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
+0.75%
INMB - OGEN
44%
Loosely correlated
+0.51%
UNBX - OGEN
36%
Loosely correlated
+5.59%
GOVX - OGEN
36%
Loosely correlated
-1.19%
ATHA - OGEN
36%
Loosely correlated
+9.07%
AUPH - OGEN
30%
Poorly correlated
-0.54%
More